{"meta":{"query_hash":"caa03f5aa2a8","filters":{"venue":"Current Prostate Reports"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/caa03f5aa2a8","api":"https://metacan.xera.ac/api/v1/cohort?venue=Current+Prostate+Reports"},"results":[{"id":"W2091334414","doi":"10.1007/s11918-008-0012-4","title":"5-α-reductase inhibitor monotherapy for lower urinary tract symptoms following combination therapy with α-blockers: When is one medication enough?","year":2008,"lang":"en","type":"article","venue":"Current Prostate Reports","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Medicine; Combination therapy; Lower urinary tract symptoms; Tamsulosin; Pharmacotherapy; Urinary system; Medical therapy; Hyperplasia; Urology; Drug; Internal medicine; Urinary retention; Drug class; Surgery; Prostate; Pharmacology","score_opus":0.05212985850046302,"score_gpt":0.3292385690339967,"score_spread":0.27710871053353364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091334414","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21114904,0.5392511,0.0017321339,0.21837924,0.011952391,0.0002870893,0.00081414456,0.0002703485,0.016164541],"genre_scores_gemma":[0.6724193,0.21698932,0.0061128433,0.067726314,0.030129744,0.0003727283,0.0009910052,0.00009898477,0.0051597385],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99676347,0.0010862842,0.0006507217,0.00025531673,0.0009144027,0.00032986],"domain_scores_gemma":[0.9840995,0.009920496,0.0024786508,0.0002542329,0.0012899985,0.0019571972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056738127,0.00084143726,0.010303135,0.00082138705,0.0014113475,0.002807689,0.0012585033,0.005915815,0.0048061614],"category_scores_gemma":[0.010549783,0.0005945363,0.003843984,0.0012355449,0.0009517419,0.0035198394,0.000510699,0.005681129,0.001173555],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040651247,0.002956165,0.11037318,0.005040273,0.007994513,0.005783101,0.00050347124,0.000724044,0.004039828,0.0012667179,0.07274073,0.74792665],"study_design_scores_gemma":[0.03348442,0.044573296,0.62758726,0.025313372,0.03528023,0.02556529,0.005389772,0.0043569147,0.0042066695,0.0076092025,0.18551128,0.0011222868],"about_ca_topic_score_codex":0.0016141289,"about_ca_topic_score_gemma":0.011417742,"teacher_disagreement_score":0.010303135,"about_ca_system_score_codex":0.0012830158,"about_ca_system_score_gemma":0.0029627401,"threshold_uncertainty_score":0.03000635},"labels":[],"label_agreement":null},{"id":"W4231044875","doi":"10.1007/s11918-006-0026-8","title":"The economics of medical therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia","year":2006,"lang":"en","type":"article","venue":"Current Prostate Reports","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Prostate; Hyperplasia; Urology; Quality of life (healthcare); Clinical trial; Benign prostatic hyperplasia (BPH); Combination therapy; Internal medicine; Prostate cancer; Intensive care medicine; Cancer","score_opus":0.023050492090825995,"score_gpt":0.3168339712341946,"score_spread":0.2937834791433686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231044875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7983148,0.053844713,0.002809833,0.048245344,0.0004758974,0.00015011258,0.0024794443,0.000048943264,0.0936309],"genre_scores_gemma":[0.992645,0.004877436,0.00024793117,0.00046480092,0.00034213194,0.000010548179,0.00015958131,0.000006438902,0.0012460279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983152,0.00092381233,0.00011704389,0.000044243214,0.0004268637,0.00017285779],"domain_scores_gemma":[0.9888263,0.0070379754,0.0024061105,0.00012746411,0.00049859216,0.0011035277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011771185,0.00015873653,0.00025588248,0.0014340886,0.00037383678,0.0017705526,0.0003690689,0.0007525026,0.0068938285],"category_scores_gemma":[0.013587243,0.0001733847,0.0008223143,0.0011029924,0.0005795084,0.0008001991,0.0007218337,0.000928683,0.0002670346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004285952,0.0009573696,0.7143074,0.0007311549,0.00080160255,0.0039273943,0.00020067967,0.013727347,0.0016706148,0.0634041,0.010087311,0.185899],"study_design_scores_gemma":[0.000348419,0.0016297671,0.9172755,0.0005310309,0.0006537861,0.012753545,0.0017543903,0.016824014,0.00092126033,0.022600582,0.024627293,0.00008044855],"about_ca_topic_score_codex":0.0044052587,"about_ca_topic_score_gemma":0.007930274,"teacher_disagreement_score":0.0068938285,"about_ca_system_score_codex":0.0033455836,"about_ca_system_score_gemma":0.0018173271,"threshold_uncertainty_score":0.024273992},"labels":[],"label_agreement":null},{"id":"W4236674915","doi":"10.1007/s11918-007-0020-9","title":"Category III chronic prostatitis/chronic pelvic pain syndrome: Insights from the National Institutes of Health Chronic Prostatitis Collaborative Research Network studies","year":2007,"lang":"en","type":"article","venue":"Current Prostate Reports","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Prostatitis; Medicine; Pelvic pain; Chronic prostatitis/chronic pelvic pain syndrome; Chronic pain; Physical therapy; Urology; Internal medicine; Prostate; Surgery","score_opus":0.09936189154730468,"score_gpt":0.4309919228613619,"score_spread":0.3316300313140572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236674915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8674233,0.04091382,0.0011283822,0.0051685083,0.00051461195,0.001359024,0.052924838,0.000037042606,0.030530414],"genre_scores_gemma":[0.9609598,0.011438645,0.0013344167,0.001186056,0.00029890766,0.0006146321,0.02279179,0.000016528558,0.0013592701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997186,0.0011718873,0.0003068881,0.00021078557,0.0008422097,0.00028214676],"domain_scores_gemma":[0.9942416,0.0012805398,0.0015116972,0.00038755103,0.0016123079,0.0009663958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041417493,0.00041119804,0.0007510139,0.0016399138,0.0008977058,0.001094873,0.00081873906,0.0005990772,0.002495512],"category_scores_gemma":[0.010030271,0.00019298689,0.0009239599,0.0043649347,0.00019805688,0.0005984451,0.0010621282,0.0007300906,0.00021848148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029580452,0.000116989206,0.9846635,0.00025599307,0.0004483252,0.00007912052,0.00017474502,0.0000486128,0.00009384672,0.00015172616,0.0048753037,0.008795995],"study_design_scores_gemma":[0.000030424882,0.000039596962,0.9979372,0.000077426164,0.00016023881,0.00006859865,0.00016674792,0.000027251734,0.00001593193,0.00004896983,0.0014230275,0.0000045155066],"about_ca_topic_score_codex":0.05994552,"about_ca_topic_score_gemma":0.12870882,"teacher_disagreement_score":0.05994552,"about_ca_system_score_codex":0.00081572775,"about_ca_system_score_gemma":0.0030732579,"threshold_uncertainty_score":0.1191932},"labels":[],"label_agreement":null}]}